Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients

医学 雄激素剥夺疗法 前列腺癌 危险系数 多西紫杉醇 内科学 肿瘤科 比例危险模型 置信区间 癌症
作者
Surabhi Pathak,Romy Jose Thekkekara,Udit Yadav,Ahmed Tarig Ahmed,Barbara Yim,Thomas E. Lad,Michael Russell Mullane,Kumar Kunnal Batra,Wilbert S. Aronow,Sarah P. Psutka
出处
期刊:American Journal of Therapeutics [Lippincott Williams & Wilkins]
卷期号:28 (4): e380-e387 被引量:2
标识
DOI:10.1097/mjt.0000000000001085
摘要

Upfront docetaxel (UD) with androgen deprivation therapy (ADT) has been demonstrated to improve survival outcomes in metastatic castration-sensitive prostate cancer (mCSPC). However, existing studies have included predominantly Caucasian patients.To compare the efficacy of addition of UD to ADT in mCSPC to ADT alone among minority patients.Retrospective study of mCSPC patients.Patients treated with UD and ADT between January 2014 and December 2017 (UD + ADT, n = 44) were compared with those treated with ADT alone between January 2008 and January 2017 (ADT, n = 38); patients of Caucasian ethnicity were excluded. The outcome of interest was progression-free survival (PFS), which was estimated using Kaplan-Meier analysis and Cox proportional hazard analysis.Overall, 63 (76.8%) patients were African American and 16 (19.5%) were Hispanic. Fifty-five (67%) patients had high-volume mCSPC. The median follow-up was 14 months [95% confidence interval (CI): 10.4-16.5] for UD + ADT and 42 months (95% CI: 17-66.9) for ADT. Median PFS did not differ between groups: UD + ADT: 16 versus ADT: 18 months [hazard ratio (HR) for UD + ADT = 0.88, 95% CI: 0.48-1.62; P = 0.70]. In patients with high-volume disease, median PFS remained similar (UD + ADT: 16 vs. ADT: 14 months (HR for UD + ADT = 0.64, 95% CI: 0.33-1.25; P = 0.19). On multivariable analysis, prolonged time to nadir PSA, HR = 0.83 (95% CI: 0.76-0.90), was independently associated with PFS. The most common toxicities in UD + ADT were anemia and fatigue. Major limitations include small sample size and potential for selection bias due to the retrospective study design.In this retrospective review of a minority mCSPC cohort, UD + ADT was not associated with improved PFS compared with ADT alone. Although further study with larger sample size is needed, these results underscore the importance of ensuring accrual of minorities in clinical trials, reflective of the real-world setting.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
orixero应助liuy采纳,获得10
1秒前
小飞机完成签到,获得积分10
1秒前
AMK完成签到,获得积分10
1秒前
bkagyin应助施施采纳,获得50
2秒前
科研通AI6.3应助持满采纳,获得10
2秒前
充电宝应助小绿绿同学采纳,获得10
2秒前
crown关注了科研通微信公众号
2秒前
4秒前
molihuakai应助舒心的不凡采纳,获得10
5秒前
BLAZe发布了新的文献求助30
6秒前
王晨发布了新的文献求助10
7秒前
7秒前
别当真发布了新的文献求助10
7秒前
8秒前
李健应助傲娇的咖啡豆采纳,获得10
8秒前
9秒前
10秒前
11秒前
ZQL发布了新的文献求助10
12秒前
乌拉挂机发布了新的文献求助10
13秒前
医一直悟发布了新的文献求助10
13秒前
pear完成签到,获得积分10
13秒前
boardblack发布了新的文献求助10
13秒前
科研通AI6.3应助Kukrushka采纳,获得10
13秒前
14秒前
西瓜鹿完成签到,获得积分10
15秒前
好久不见发布了新的文献求助10
15秒前
俏皮的聪展完成签到,获得积分10
15秒前
16秒前
搜集达人应助踏实的可愁采纳,获得10
17秒前
在水一方应助黑虎阿福采纳,获得10
17秒前
molihuakai应助AMK采纳,获得10
17秒前
19秒前
11完成签到,获得积分10
21秒前
haha发布了新的文献求助10
21秒前
JamesPei应助xiao_niu采纳,获得10
21秒前
yw发布了新的文献求助10
21秒前
雪蛤发布了新的文献求助20
22秒前
22秒前
高分求助中
Malcolm Fraser : a biography 680
Signals, Systems, and Signal Processing 610
天津市智库成果选编 600
Climate change and sports: Statistics report on climate change and sports 500
Forced degradation and stability indicating LC method for Letrozole: A stress testing guide 500
全相对论原子结构与含时波包动力学的理论研究--清华大学 500
Organic Reactions Volume 118 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6455392
求助须知:如何正确求助?哪些是违规求助? 8266023
关于积分的说明 17617786
捐赠科研通 5521529
什么是DOI,文献DOI怎么找? 2904915
邀请新用户注册赠送积分活动 1881625
关于科研通互助平台的介绍 1724563